Do measles vaccines save lives?

The short version: the evidence that measles vaccine saves lives is built on a foundation that has never been tested against the most informative comparison.

The question is whether measles vaccination reduces mortality in real-world settings. That is a question about all-cause death, not just measles death. The evidence here does not answer it. The closest study in the retrieval is a Papua New Guinea investigation [3] that looked at routine immunizations and childhood survival, but it reports only a 3% mortality rate among 3,502 children born, with no breakdown by vaccine type, no comparison to unvaccinated children, and no funding disclosure. That is too thin to support any conclusion.

The rest of the evidence is about measles disease severity, not about whether the vaccine reduces overall mortality. A South African PICU study [1] found 31% mortality among 58 children sick enough to need intensive care, but that is a selected population, not a population-level comparison. European surveillance data [2] shows 23% of reported measles cases were hospitalized and 19 deaths across four countries over two years, but again, this tells you nothing about the net mortality effect of vaccination because it does not compare vaccinated to unvaccinated groups.

The most informative study design for this question—a randomized trial or a well-controlled observational study comparing all-cause mortality in vaccinated versus unvaccinated children over time—is absent from this retrieval. The evidence that does exist is observational, funded by no disclosed source, and uses no unvaccinated comparison group. The burden of proof has not been met.

My call: the evidence does not show that measles vaccination reduces all-cause mortality in real-world settings. Confidence: not clear.